A PHASE 3 EFFICACY AND SAFETY STUDY OF FOSMANOGEPIX FOR THE TREATMENT OF ADULT PARTICIPANTS WITH INVASIVE MOLD INFECTIONS
Research Grant
Awarded By
Basilea Pharmaceutica
Start Date
September 1, 2026
End Date
May 31, 2029
Awarded By
Basilea Pharmaceutica
Start Date
September 1, 2026
End Date
May 31, 2029